Original language | English |
---|---|
Pages (from-to) | 824-828 |
Number of pages | 5 |
Journal | European Journal of Gynaecological Oncology |
Volume | 42 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2021 Oct 15 |
ASJC Scopus subject areas
- Oncology
- Obstetrics and Gynaecology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Potential biomarkers associated with malignancy in uterine mesenchymal tumors. / Hayashi, Takuma; Yaegashi, Nobuo; Tonegawa, Susumu et al.
In: European Journal of Gynaecological Oncology, Vol. 42, No. 5, 15.10.2021, p. 824-828.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Potential biomarkers associated with malignancy in uterine mesenchymal tumors
AU - Hayashi, Takuma
AU - Yaegashi, Nobuo
AU - Tonegawa, Susumu
AU - Konishi, Ikuo
N1 - Funding Information: This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation. Funding Information: We sincerely appreciate the generous donation of PSMB9/β1i-deficient breeding mice and technical comments by Luc Van Kaer, at Massachusetts Institute of Technology. We thank Isamu Ishiwata for his generous gift of the human Ut-LMS cell lines. We appreciate the technical assistance of the research staff at Harvard Medical School. We are grateful to clinical staffs at Hyogo Cancer Center for Adults for clinical materials and helpful discussion. This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation.
PY - 2021/10/15
Y1 - 2021/10/15
UR - http://www.scopus.com/inward/record.url?scp=85118513484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118513484&partnerID=8YFLogxK
U2 - 10.31083/j.ejgo4205125
DO - 10.31083/j.ejgo4205125
M3 - Review article
AN - SCOPUS:85118513484
VL - 42
SP - 824
EP - 828
JO - European Journal of Gynaecological Oncology
JF - European Journal of Gynaecological Oncology
SN - 0392-2936
IS - 5
ER -